| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 5.351 | 8.695 | 18.230 | 26.119 | 32.262 | 22.698 | 21.446 | 20.975 | 37.590 | 46.347 |
| Total Income - EUR | 5.455 | 8.695 | 18.230 | 26.119 | 32.262 | 22.819 | 27.632 | 20.975 | 52.490 | 46.352 |
| Total Expenses - EUR | 710 | 1.446 | 1.376 | 8.404 | 14.639 | 19.912 | 19.751 | 14.524 | 26.797 | 23.193 |
| Gross Profit/Loss - EUR | 4.745 | 7.249 | 16.854 | 17.715 | 17.623 | 2.908 | 7.881 | 6.450 | 25.693 | 23.160 |
| Net Profit/Loss - EUR | 4.584 | 6.988 | 16.307 | 16.931 | 16.655 | 2.226 | 7.238 | 5.821 | 21.414 | 19.203 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Dermadeldya Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 115 | 1.426 | 1.162 | 29.454 | 23.644 | 19.481 | 12.766 | 7.150 | 27.511 | 21.305 |
| Current Assets | 5.723 | 5.794 | 22.245 | 28.304 | 14.043 | 13.294 | 3.077 | 502 | 34.191 | 22.558 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 22 | 221 | 217 | 213 | 430 | 0 | 0 | 0 | 528 | 527 |
| Cash | 5.701 | 5.573 | 22.028 | 28.091 | 13.613 | 13.294 | 3.077 | 502 | 33.663 | 22.032 |
| Shareholders Funds | 5.753 | 7.042 | 23.230 | 31.139 | 16.706 | 18.615 | 7.489 | 5.870 | 21.462 | 19.252 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 85 | 178 | 178 | 26.619 | 21.144 | 15.466 | 8.718 | 2.029 | 40.331 | 24.633 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Dermadeldya Srl